---
title: "NHWA released its performance for the first three quarters, with a net profit attributable to the parent company of 1.106 billion yuan, a year-on-year increase of 8.42%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/262570698.md"
description: "According to the Zhitong Finance APP, NHWA released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 4.471 billion yuan, a year-on-year increase of 7.85%. The net profit attributable to shareholders of the listed company was 1.106 billion yuan, a year-on-year increase of 8.42%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.109 billion yuan, a year-on-year increase of 7.59%"
datetime: "2025-10-24T08:27:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262570698.md)
  - [en](https://longbridge.com/en/news/262570698.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262570698.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/262570698.md) | [繁體中文](https://longbridge.com/zh-HK/news/262570698.md)


# NHWA released its performance for the first three quarters, with a net profit attributable to the parent company of 1.106 billion yuan, a year-on-year increase of 8.42%

According to the Zhitong Finance APP, NHWA (002262.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 4.471 billion yuan, a year-on-year increase of 7.85%. The net profit attributable to shareholders of the listed company was 1.106 billion yuan, a year-on-year increase of 8.42%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.109 billion yuan, a year-on-year increase of 7.59%

### 相关股票

- [NHWA (002262.CN)](https://longbridge.com/zh-CN/quote/002262.CN.md)

## 相关资讯与研究

- [Nhwa Pharmaceutical's Sulpiride Hydrochloride Tablets Passes Regulatory Consistency Evaluation](https://longbridge.com/zh-CN/news/268699160.md)
- [In 2025, EBITDA increased by more than 10% year over year, while revenue grew by over 11%.](https://longbridge.com/zh-CN/news/279129868.md)
- [11:15 ETInventHelp Inventor Develops New Hospital Door Access System (SGM-650)](https://longbridge.com/zh-CN/news/278908809.md)
- [11:45 ETInventHelp Inventor Develops New Baby Bottle Support (SGM-657)](https://longbridge.com/zh-CN/news/278912625.md)
- [11:30 ETInventHelp Inventor Develops New Transport Device for Hunters (SGM-654)](https://longbridge.com/zh-CN/news/278911055.md)